Adherium Limited (ASX:ADR)

Market Cap	10.75M +1.2%
Revenue (ttm)	1.12M +16.0%
Net Income	-12.76M
EPS	-0.01
Shares Out	5.37B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,800,000
Open	0.0010
Previous Close	0.0015
Day's Range	0.0010 - 0.0010
52-Week Range	0.0010 - 0.0080
Beta	1.01
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Adherium

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melb...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 40
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ADR

Financial Performance

In fiscal year 2025, Adherium's revenue was 817,237, a decrease of -2.82% compared to the previous year's 840,982. Losses were -12.68 million, 24.0% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 26, 2026

Data Sources Report a data error